TODAY'S HEADLINES

FDA approves GVHD treatment

Why FDA granted breakthrough therapy designation to ruxolitinib (Jakafi), the first treatment for acute graft-versus-host disease (GVHD). Read more

FDA approves rare liver disease drug

FDA recently granted accelerated approval for obeticholic acid (Ocaliva) for this rare liver disease. Read more

CONTINUING PHARMACY EDUCATION

The rundown: Management of acute and chronic diarrhea

This month's CE activity, "The rundown: Management of acute and chronic diarrhea," is open for pharmacists and pharmacy technicians.
The goal of this activity is to review the various risk factors, etiologies, and treatments of diarrhea as well as the pharmacist's role in its management.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

First cholera vaccine available

FDA approved the first single-dose vaccine for cholera currently licensed anywhere in the world. Why the need is increased

June 29, 2016

Related Articles

FDA approves Zinbryta to treat multiple sclerosis

First drug approved for hallucinations in Parkinson's